287
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Application of near-infrared spectroscopy to optimize dissolution profiles of tablets according to the granulation mechanism

, , &
Pages 713-722 | Received 09 May 2017, Accepted 28 Nov 2017, Published online: 14 Dec 2017

References

  • Faure A, York P, Rowe RC. Process control and scale-up of pharmaceutical wet granulation processes: a review. Eur J Pharm Biopharm. 2001;52:269–277.
  • Briens L, Logan R. The effect of the chopper on granules from wet high-shear granulation using a PMA-1 Granulator. AAPS PharmSciTech. 2011;12:1358–1365.
  • Pandey P, Badawy S. A quality by design approach to scale-up of high-shear wet granulation process. Drug Dev Ind Pharm. 2016;42:175–189.
  • Badawy SF, Narang AS, LaMarche K, et al. Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation. Int J Pharm. 2012;439:324–333.
  • Tao J, Pandey P, Bindra DS, et al. Evaluating scale-up rules of a high-shear wet granulation process. J Pharm Sci. 2015;104:2323–2333.
  • Pandey P, Tao J, Chaudhury A, et al. Combined experimental and modeling approach to study the effects of high-shear wet granulation process parameters on granule characteristics. Pharm Dev Technol. 2013;18:210–224.
  • Badawy SF, Menning MM, Gorko MA, et al. Effect of process parameters on compressibility of granulation manufactured in a high-shear mixer. Int J Pharm. 2000;198:51–61.
  • US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research. 2004. Guidance for industry, PAT-a framework for innovative pharmaceutical development, manufacturing, and quality assurance. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInforma-tion/Guidances/ucm070305.pdf
  • De Beer T, Burggraeve A, Fonteyne M, et al. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes. Int J Pharm. 2011;417:32–47.
  • Reich G. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv Drug Deliv Rev. 2005;57:1109–1143.
  • Li W, Bashai-Woldu A, Ballard J, et al. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models. Int J Pharm. 2007;340:97–103.
  • Li W, BagnoL l, Berman M, et al. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis. Int J Pharm. 2009;380:49–54.
  • Miwa A, Yajima T, Itai S. Prediction of suitable amount of water addition for wet granulation. Int J Pharm. 2000;195:81–92.
  • Miwa A, Yajima T, Ikuta H, et al. Prediction of suitable amounts of water in fluidized bed granulation of pharmaceutical formulations using corresponding values of components. Int J Pharm. 2008;352:202–208.
  • Miwa A, Makado K. A method for predicting the amount of water required for wet granulation using NIR. Int J Pharm. 2009;376:41–45.
  • Vemavarapu C, Surapaneni M, et al. Role of drug substance material properties in the processibility and performance of a wet granulated product. Int J Pharm. 2009;374:96–105.
  • Rowe RC. Characterization of wet powder masses using a mixer torque rheometer. 4. Effect of blade orientation. Int J Pharm. 1996;133:133–138.
  • Shah RB, Tawakkul MA, Khan MA. Process analytical technology: chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets. J Pharm Sci. 2007;96:1356–1365.
  • Chitu TM, Oulahna D, Hemati M. Rheology, granule growth and granule strength: application to the wet granulation of lactose-MCC mixtures. Powder Technol. 2011;208:441–453.
  • Leuenberger H. New trends in the production of pharmaceutical granules: the classical batch concept and the problem of scale-up. Eur J Pharm Biopharm. 2001;52:279–288.
  • Kumar A, Gernaey KV, Beer TD, et al. Model-based analysis of high shear wet granulation from batch to continuous processes in pharmaceutical production – a critical review. Eur J Pharm Biopharm. 2013;85:814–832.
  • Iveson SM, Lister JD, Hapgood K, et al. Nucleation, growth and breakage phenomena in agitated wet granulation process: a review. Powder Technol. 2001;117:3–39.
  • Hancock BC, York P, Rowe RC. Assessment of substrate-binder interactions in model wet masses. 1: mixer torque rheometry. Int J Pharm. 1994;102:167–176.
  • Uemura T, Uramatsu S, Morizane M, et al. Usefulness of mixer torque rheometer for pharmaceutical design. Pharm Tech Japan. 2012;28:125–131.
  • Simpson MB. Chapter 3, Near-infrared spectroscopy for process analytical chemistry: theory, technology and implementation. In: Bakeev KA, editor. Process analytical technology. UK: Blackwell Publishing Ltd; 2005. p. 39–90.
  • Schwanninger M, Rodrigues JC, Fackler K. A review of band assignments in near infrared spectra of wood and wood components. J Near Infrared Spectrosc. 2011;19:287–308.
  • Hattori Y, Otsuka M. Time-resolved near-infrared spectroscopic study of the dissolution of crystalline lactose. Eur J Pharm Sci. 2012;47:884–889.
  • Hattori Y, Otsuka M. NIR spectroscopic study of the dissolution process in pharmaceutical tablets. Vib Spectrosc. 2011;57:275–281.
  • Buckton G, Yonemochi Y, Hammond J, et al. The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactose. Int J Pharm. 1998;168:231–241.
  • Luukkonen P, Rantanen J, Mäkelä K, et al. Characterization of wet massing behavior of silicified microcrystalline cellulose and α-lactose monohydrate using near-infrared spectroscopy. Pharm Dev Technol. 2001;6:1–9.
  • Gombás Á, Antal I, Szabó-Révész P, et al. Quantitative determination of crystallinity of alpha-lactose monohydrate by near infrared spectroscopy (NIRS). Int J Pharm. 2003;256:25–32.
  • Fix I, Steffens J. Quantifying low amorphous or crystalline amounts of alpha-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry. Drug Dev Ind Pharm. 2004;30:513–523.
  • Smirani-Khayati N, Falk V, Bardin-Monnier N, et al. Binder liquid distribution during granulation process and its relationship to granule size distribution. Powder Technol. 2009;195:105–112.
  • Pearson JMK, Hounslow MJ, Instone T. Tracer studies of high-shear granulation: I. Experimental results. AIChE J. 2001;47:1978–1983.
  • Tan HS, Salman AD, Hounslow MJ. Kinetics of fluidized bed melt granulation III: tracer studies. Chem Eng Sci. 2005;60:3835–3845.
  • Bouwman AM, Henstra MJ, Westerman D, et al. The effect of the amount of binder liquid on the granulation mechanisms and structure of microcrystalline cellulose granules prepared by high shear granulation. Int J Pharm. 2005;290:129–136.
  • US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research. 1997. Guidance for industry, Dissolution testing of immediate release dosage forms. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070237.pdf
  • Yaro Y, Xin H, Liu W, et al. In vitro–in vivo correlations for three different commercial immediate-release indapamide tablets. Drug Dev Ind Pharm. 2014;40:1670–1676.
  • Sherif I, Farag B, David BG, et al. A study on the effect of wet granulation on microcrystalline cellulose particle structure and performance. Pharm Res. 2006;23:634–640.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.